CL
FOLD

CSS LLC’s Amicus Therapeutics FOLD Stock Holding History

CSS LLC’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,000
Closed -$301K – 546
2018
Q1 		$301K Sell
20,000
-20,000
-50% -$304K 0.02% 362
2017
Q4 		$576K Buy
40,000
+29,000
+264% +$398K 0.03% 323
2017
Q3 		$166K Buy
+11,000
New +$146K 0.01% 512

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

CSS LLC's FOLD Position: Q1 2026 in Review

CSS LLC opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 33,500 shares worth $484K. The stake represents 0.02% of the portfolio and ranks #534 among its holdings. This is a return to the name: CSS LLC previously reported a position in FOLD as recently as Q4 2020.

CSS LLC first reported a position in FOLD in Q1 2019 and has held it in 7 quarters since. The position peaked at $701K in Q2 2019. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • CSS LLC held 33,500 shares of Amicus Therapeutics worth $484K as of Q1 2026.
  • Amicus Therapeutics was a new CSS LLC position in Q1 2026.
  • Amicus Therapeutics made up 0.02% of CSS LLC's portfolio in Q1 2026, its #534 holding.
  • CSS LLC first reported a position in Amicus Therapeutics in Q1 2019 and has held it in 7 quarters since.
  • CSS LLC's Amicus Therapeutics position peaked at $701K in Q2 2019.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.